facilitate follow-on innovation and benefit latecomer firms, especially in the pharmaceutical industry. In this paper, we provide … between firms' innovation and imitation strategies for the design of innovation policies …

For more than a decade, China has been the world's leading supplier of active pharmaceutical ingredients. Today, it is … not only the world's second largest pharmaceutical market, behind only the United States, but it also produces about four … percent of the world's new pharmaceutical products. Despite these impressive accomplishments, China does not have …

This study investigates how enhanced regulation can promote innovation, focusing on the impacts of a significant … recognized the improvement in drug innovation, as reflected in stock price adjustments post new drug registrations after the … latecomers could boost their innovation potential by adopting specific, effective regulatory practices from frontier countries …

differences between China and the Western world. For a better understanding of the drug registration process, it explores the …--and those of the Western world. The volume discusses disparities between China's application requirements compared to Western …

and legal reforms: Gateway to innovation and global integration -- Chapter 3: The golden age of the Chinese biopharma …: Explosive growth in a thriving ecosystem -- Chapter 4: Innovation in the Chinese biopharma: From me-too to First … country with no innovation in drug discovery, to a country which starts to out-license its biopharma technology to the rest of …